“Preparing for novelty and non-obviousness arguments [with respect to solid form claims] often involves coordination among patent practitioners and inventors/scientists.” Claimed inventions in issued ...

“In re Baird illustrates that the disclosure of a genus in the prior art is not necessarily a disclosure of every species that is a member of that genus. Patentees can use this concept to their ...

Early stage drug delivery formulations are complex mixtures which contain solid particles, with the main constituent being polymers. When the polymers are mixed into a drug formulation, they often ...

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 02, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (CDT) (“CDT” or the “Company”), today announced that it has engaged NJS Foresight Bio-Advisory, LLC to ...

In this interview, Dr. Matteo Daldosso, Physical Properties Unit manager at Aptuit and Dr. Sebastian Wegner, Product Manager of Solid-state NMR at Bruker Biospin, discuss novel solutions for solid ...